Open AccessDOAJ SealDOAJCrossrefOpenAlex
mAbs
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Taylor & Francis Group
- Subjects
- antibodies · antibody engineering · antibody therapeutics · Biosimilars and Bioanalytical Methods · cancer · CAR-T cell therapy research · Glycosylation and Glycoproteins Research · HER2/EGFR in Cancer Research · Immunologic diseases. Allergy · immunology · Monoclonal and Polyclonal Antibodies Research · Protein purification and stability · T-cell and B-cell Immunology · Therapeutics. Pharmacology · Viral Infectious Diseases and Gene Expression in Insects
- Country
- GB
- Languages
- EN
- ISSN
- 1942-0862
- E-ISSN
- 1942-0870
- ISSN-L
- 1942-0862
- Open access
- Yes
- OA since
- 2019
- Publication years
- 1967–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Medicine
- Primary Subfield
- Radiology, Nuclear Medicine and Imaging
- Domain
- Health Sciences
- Confidence
- High
- Publications classified
- 230
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 2,915 GBP
- DOAJ · 2026
- 6,110 AUD
- DOAJ · 2026
- 4,215 EUR
- DOAJ · 2026
- 3,510 GBP
- DOAJ · 2026
- 4,390 USD
